9780824708160

Pediatric Endocrinology, Fourth Edition

by ;
  • ISBN13:

    9780824708160

  • ISBN10:

    0824708164

  • Edition: 4th
  • Format: Hardcover
  • Copyright: 2003-01-31
  • Publisher: CRC Press

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $249.95 Save up to $62.49
  • Buy Used
    $187.46
    Add to Cart Free Shipping

    USUALLY SHIPS IN 2-4 BUSINESS DAYS

Supplemental Materials

What is included with this book?

Summary

The fourth edition of this text presents breakthroughs in the diagnosis, treatment, and control of children with endocrine and endocrine-related disorders. It addresses every condition and situation encountered in day-to-day clinical practice - from growth abnormalities and thyroid disease to diabetes, obesity and hypertension.

Table of Contents

About the Series iv
Foreword v
Robert M. Blizzard
Foreword v
Maria I. New
Preface vii
Contributors xxi
Online References Cited in Text xxv
I. GROWTH AND GROWTH DISORDERS
Worrisome Growth
1(46)
Fima Lifshitz
Diego Botero
The General Problem
1(1)
The Medical Problem
2(1)
Diagnosis of Short Stature
3(1)
Growth Patterns
4(6)
Constitutional Growth Delay
10(3)
Familial Short Stature
13(1)
Pathological Short Stature
14(1)
Intrauterine Growth Retardation
15(5)
Failure to Thrive
20(5)
Nutritional Growth Retardation
25(9)
Laboratory Aids in Differentiating Short Stature
34(1)
Final Considerations
35(12)
References
35(12)
Hypopituitarism and Other Disorders of the Growth Hormone and Insulin-Like Growth Factor Axis
47(40)
Arlan L. Rosenbloom
Ellen Lancon Connor
Introduction
47(1)
Pituitary Gland, Growth Hormone, and IGF-I
47(7)
Classification of Disorders Involving the GH/IGF-I Axis
54(1)
Congenital GH Deficiency
54(4)
Acquired GH Deficiency
58(6)
Congenital GH Insensitivity
64(3)
Acquired GH Insensitivity
67(1)
Primary IGF-I Deficiency and IGF-I Resistance
67(1)
Diagnostic Evaluation
68(6)
Treatment
74(13)
References
78(9)
Growth Hormone Treatment
87(26)
David B. Allen
Introduction
87(1)
Growth Hormone Physiology
88(1)
Growth Hormone Effects
89(1)
Growth Hormone Deficiency
90(5)
Idiopathic Short Stature and Constitutional Growth Delay
95(2)
Turner Syndrome and Noonan Syndrome
97(1)
Intrauterine Growth Retardation
98(1)
Chronic Renal Failure and Hypophosphatemic Rickets
99(1)
Skeletal Dysplasias
99(1)
Glucocorticoid-Treated Children
100(1)
Prader-Willi Syndrome
101(1)
Other Syndromes and Defects Associated with Short Stature
102(1)
Adults with GH Deficiency and the Elderly
102(1)
Catabolic States
103(1)
Adverse Effects of GH Treatment
103(2)
Ethical Issues in GH Treatment
105(8)
References
106(7)
Skeletal Dysplasias
113(20)
Mordechai Shohat
David L. Rimoin
Introduction
113(1)
Differentiation
113(1)
International Classification and Nomenclature
114(1)
Diagnosis and Assessment
114(15)
Prenatal Diagnosis
129(1)
Management
129(1)
Extended Limb Lengthening
129(1)
Growth Hormone Therapy in Achondroplasia
130(1)
Collection of Skeletal Tissues
130(3)
References
131(2)
Tall Stature and Excessive Growth Syndromes
133(14)
S. Douglas Frasier
Definition and Classification of Overgrowth Syndromes
133(1)
Growth Hormone Excess
133(2)
Cerebral Gigantism (Sotos Syndrome)
135(2)
Klinefelter Syndrome
137(1)
XYY Syndrome
138(1)
Marfan Syndrome
138(1)
Homocystinuria
139(1)
Beckwith-Wiedemann Syndrome
140(1)
Hemihypertrophy
141(1)
Constitutional Tall Stature
141(6)
References
143(4)
II. ADRENAL DISORDERS AND SEXUAL DEVELOPMENT ABNORMALITIES
Adrenal Cortex: Hypo- and Hyperfunction
147(28)
Claude J. Migeon
Roberto L. Lanes
Introduction
147(1)
Physiology
147(7)
Hypoadrenocorticism
154(1)
Hypoadrenocorticism: Primary Adrenocortical Insufficiency
154(5)
Addison's Disease (Chronic Hypoadrenocorticism)
159(1)
Hypoadrenocorticism Secondary to Deficient CRH and/or ACTH Secretion
160(2)
Hypoadrenocorticism Secondary to End-Organ Unresponsiveness
162(1)
Treatment of Hypoadrenocorticism
163(1)
Hyperadrenocorticism
163(1)
Hypercortisolism
164(2)
Adrenogenital Syndrome
166(1)
Feminizing Adrenal Tumors
167(1)
Hyperaldosteronism
168(7)
References
170(5)
Congenital Adrenal Hyperplasia
175(18)
Maria I. New
Lucia Ghizzoni
Introduction
175(1)
Pathophysiology
175(3)
Clinical Features
178(1)
Clinical Forms of Adrenal Hyperplasia Caused by 21-Hydroxylase Deficiency
178(3)
Pubertal Maturation in Classical Congenital Adrenal Hyperplasia
181(2)
Genetics
183(1)
Epidemiology
183(1)
Diagnosis
183(4)
Treatment
187(1)
Conclusion
187(6)
References
187(6)
Disorders of the Adrenal Medulla: Catecholamine-Producing Tumors in Childhood
193(18)
Karel Pacak
Martina Weise
Graeme Eisenhofer
Frederieke M. Brouwers
Christian A. Koch
The Catecholamines
193(1)
Pheochromocytoma
194(3)
Multiple Endocrine Neoplasia Syndromes
197(2)
Neuroblastoma
199(4)
Ganglioneuroma
203(1)
Neural Tumors and Chronic Diarrhea
203(8)
References
203(8)
Puberty and Its Disorders
211(28)
Peter A. Lee
Normal Puberty
211(3)
Precocious Puberty
214(9)
Therapy
223(2)
Partial Pubertal Development: Variants of Normal
225(1)
Inappropriate Sex-Steroid-Stimulated Changes for Sex
226(1)
Delayed Puberty and Hypogonadism Presenting During Adolescence
227(12)
References
235(4)
Turner Syndrome
239(18)
E. Kirk Neely
Ron G. Rosenfeld
Introduction
239(1)
Features of Turner Syndrome
239(8)
The Genetic Basis of TS
247(2)
Medical Therapies
249(8)
References
252(5)
Nonendocrine Vaginal Bleeding
257(20)
Albert Altchek
Introduction
257(1)
Causes of Local Nonendocrine Bleeding
258(1)
Severe Vaginal Infections as a Cause of Local Nonendocrine Bleeding
259(1)
Trauma as a Cause of Local Nonendocrine Bleeding
260(1)
Foreign Bodies in the Vagina as a Cause of Local Nonendocrine Bleeding
261(1)
Vulvar Lesions as a Cause of Local Nonendocrine Bleeding
261(4)
Prolapse of the Urethra as a Cause of Local Nonendocrine Bleeding
265(1)
Anal Lesions as a Cause of Local Nonendocrine Bleeding
265(1)
Polyps of the Hymen as a Cause of Local Nonendocrine Bleeding
266(1)
Malignant and Benign Tumors of the Vagina, Uterus, and Ovaries
266(2)
Coagulation Defects as a Cause of Local Nonhormonal Bleeding
268(2)
Evaluation
270(2)
Conclusion
272(5)
References
273(4)
Hirsutism, Polycystic Ovary Syndrome, and Menstrual Disorders
277(42)
Songya Pang
Introduction
277(1)
Physiology of Androgen Metabolism
277(5)
Physiology of Hair Growth, Proposed Intradermal Immunoregulation, and Skin Androgen Metabolism
282(2)
Pathophysiology and Causes of Hirsutism and Polycystic Ovary Syndrome
284(10)
Diagnostic Approach and Differential Diagnosis
294(4)
Treatment of Hirsutism and Polycystic Ovary Syndrome
298(3)
Menstrual Disorders in Adolescents
301(18)
References
309(10)
Disorders of Sexual Differentiation
319(28)
Adriana A. Carrillo
Marco Danon
Gary D. Berkovitz
Gonadal Differentiation
319(1)
Anatomical Sex Differentiation of the Reproductive Tract
320(3)
Hormonal Control of Sex Differentiation
323(2)
Ambiguous Genitalia
325(9)
Diagnostic Evaluation for Ambiguous Genitalia
334(2)
Management of Intersex
336(3)
Micropenis
339(1)
Hypospadias
339(1)
Cryptorchidism
340(7)
References
342(5)
III. THYROID DISORDERS
Thyroid Disorders in Infancy
347(12)
Guy Van Vliet
Introduction
347(1)
Changes in Thyroid Hormone Economy from Conception to 3 Years of Age
347(1)
Congenital Hypothyroidism
348(5)
Hypothyroxinemia of the Newborn
353(1)
Congenital Hyperthyroidism
354(1)
Acquired Hypo- and Hyperthyroidism in Infancy
355(1)
Structural Thyroid Problems
355(1)
Conclusion
356(3)
References
356(3)
Hypothyroidism
359(12)
John S. Dallas
Thomas P. Foley, Jr.
Historical Background
359(1)
Classification and Causes
360(2)
Pathophysiology
362(1)
Clinical Presentation
362(2)
Diagnostic Evaluation
364(2)
Clinical Course and Management
366(5)
References
368(3)
Hyperthyroidism
371(22)
John S. Dallas
Thomas P. Foley, Jr.
Pathogenesis and Etiology
371(1)
Graves' Disease
371(4)
Autonomous Thyroid Nodule
375(1)
Familial Nonautoimmune Hyperthyroidism
376(1)
TSH-Induced Hyperthyroidism
377(1)
Subacute and Hashimoto's Thyroiditis
378(1)
Exogenous Thyroid Hormone
378(1)
Euthyroid Hyperthyroxinemia
379(2)
T3 and T4 Toxicosis
381(1)
Graves' Ophthalmopathy
382(1)
Laboratory Evaluation
383(1)
Prognosis and Treatment
384(9)
References
388(5)
Thyromegaly
393(14)
John S. Dallas
Thomas P. Foley, Jr.
Introduction
393(1)
Pathogenesis
393(1)
Autoimmune Thyroid Disease: Thyroiditis
394(5)
Acute and Subacute Thyroiditis
399(1)
Iodine Deficiency
400(1)
Goitrogens
400(1)
Familial Thyroid Dyshormonogenesis
400(1)
Idiopathic Goiter
401(1)
Nodular Thyromegaly
402(1)
Evaluation of Patients with Thyromegaly
403(4)
References
404(3)
Thyroid Tumors in Children
407(14)
Donald Zimmerman
Epidemiology
407(1)
Pathology
408(3)
Pathogenesis
411(3)
Diagnosis
414(1)
Treatment
414(7)
References
417(4)
IV. DISORDERS OF CALCIUM AND PHOSPHORUS METABOLISM
Hypoparathyroidism and Mineral Homeostasis
421(60)
Jaakko Perheentupa
Introduction
421(1)
Physiological Background: The Parathyroid Glands and Hormones
421(2)
Calcitriol (1,25-Dihydroxycalciferol)
423(2)
The Kidneys
425(3)
The Skeleton
428(1)
The Intestine
429(1)
Calcium, Phosphate, and Magnesium in Plasma
429(1)
Manifestations of Deficient Parathyroid Hormone Action
430(2)
Causes of Hypoparathyroidism
432(1)
Familial Isolated Hypoparathyroidism
432(1)
Autoimmune Polyendocrinopathy-Candidiasis--Ectodermal Dystrophy (APECED) (MIM 240300)
433(4)
Hypoparathyroidism of Dysmorphic Syndromes
437(5)
Transient Hyperparathyroidism
442(2)
Other Acquired Hypoparathyroidism
444(1)
Pseudohypoparathyroidism
444(5)
Diagnosis
449(4)
Therapy
453(16)
References
457(12)
Hyperparathyroidism in Children
Scott A. Rivkees
Thomas O. Carpenter
Introduction
469(1)
The Parathyroid Glands
469(1)
Parathyroid Hormone and Regulation of Its Secretion
470(1)
Assays for Parathyroid Hormone
470(1)
PTH/PtHrP Receptors
470(1)
Mechanism of Parathyroid Hormone Action
471(1)
Pathogenesis of Hyperparathyroidism
471(1)
Differential Diagnosis
472(1)
Recognition and Diagnosis
472(1)
Primary Hyperparathyroidism
473(1)
Secondary and Tertiary Hyperparathyroidism
473(1)
Complications of Hyperparathyroidism and Hypercalcemia
474(1)
Treatment of Hyperparathyroidism and Hypercalcemia
474(1)
Management After Parathyroidectomy
475(1)
Summary
475(6)
References
476(5)
Neonatal Calcium and Phosphorus Disorders
481(36)
Winston W. K. Koo
Introduction
481(1)
Maintenance of Calcium and Phosphorus Homeostasis
481(2)
Hormonal Control of Calcium and P Homeostasis via PTH, CT, and 1,25(OH)2D
483(7)
Nonclassic Control of Calcium and P Homeostasis
490(1)
Hypocalcemia
491(6)
Hypercalcemia
497(3)
Hypophosphatemia
500(2)
Hyperphosphatemia
502(1)
Skeletal Manifestations of Disturbed Mineral Homeostasis
503(14)
References
505(12)
Metabolic Bone Disease
517(24)
Joseph M. Gertner
Introduction
517(1)
Rickets
517(3)
Disorders of Vitamin D Metabolism
520(1)
Disorders of Phosphate Homeostasis
521(4)
Ricketslike Conditions
525(1)
Metabolic and Genetic Disorders Intrinsic to the Skeleton
526(5)
Skeletal Dysplasia
531(3)
Treatment of Skeletal Disorders
534(7)
References
536(5)
V. HYPOGLYCEMIA AND DIABETES MELLITUS
Hypoglycemia in the Newborn, Including the Infant of a Diabetic Mother
541(34)
Hussien M. Farrag
Richard M. Cowett
Introduction
541(1)
Neonatal Euglycemia and Hypoglycemia
541(6)
Glucose Metabolism
547(6)
Clinical Assessment
553(2)
Preterm Appropriate for Gestational Age Neonates
555(1)
Small for Gestational Age Infants
555(2)
Congenital Heart Disease/Congestive Heart Failure
557(1)
Perinatal Stress/Hypoxia
557(1)
Cold Injury and Sepsis
557(1)
Hyperinsulinism: The Infant of the Diabetic Mother
558(2)
Rh Incompatability and Hypoglycemia
560(1)
Exchange Transfusion and Umbilical Catheter
560(1)
Persistent Hyperinsulinemic Hypoglycemia
561(1)
Hypoglycemia Following Maternal Ethanol Consumption and Miscellaneous Causes
562(1)
Beckwith-Wiedemann Syndrome
563(1)
Defective Gluconeogenesis/Glycogenolysis
563(1)
Evaluation
563(1)
Treatment
564(11)
References
568(7)
Hypoglycemia in Children
575(36)
Joseph I. Wolfsdorf
David A. Weinstein
Introduction
575(1)
Definition of Hypoglycemia
575(1)
Overview of Fuel Metabolism
576(3)
Regulation of Insulin Secretion
579(1)
Clinical Manifestations of Hypoglycemia
580(1)
Causes of Hypoglycemia in Infants and Children
581(2)
Hyperinsulinism
583(2)
Hormone Deficiency
585(1)
Disorders of Glycogen Synthesis and Glycogen Degradation
586(3)
Disorders of Gluconeogenesis
589(1)
Disorders of Amino Acid Metabolism
590(1)
Miscellaneous Causes of Hypoglycemia
591(1)
Disorders of Carnitine Metabolism, Fatty Acid β-Oxidation, and Ketone Synthesis
592(4)
Determining the Cause of Hypoglycemia
596(2)
Treatment
598(1)
Hypoglycemia and Diabetes Mellitus
598(13)
References
603(8)
Diabetes in the Child and Adolescent
611(42)
Arlan L. Rosenbloom
Janet H. Silverstein
Introduction
611(1)
Diagnosis and Classification
611(3)
Type 1 Diabetes
614(13)
Type 2 Diabetes
627(12)
Other Types of Diabetes
639(14)
References
641(12)
Management of the Child with Diabetes
653(16)
Oscar Escobar
Dorothy J. Becker
Allan L. Drash
Introduction
653(1)
Metabolic Disturbances as a Consequence of Insulin Deficiency
653(1)
Management
654(1)
Insulin Therapy
654(2)
Intensive Diabetes Therapy
656(1)
Somogyi Effect and Dawn Phenomenon
657(1)
Dietary Management
658(1)
Exercise as a Therapeutic Modality
659(1)
Education and Emotional Support
659(1)
The Therapeutic Team
660(1)
Therapeutic Objectives and Monitoring Requirements
661(3)
Consultations and Referrals
664(1)
Clinical Assessment and Therapeutic Decision-Making
665(4)
References
666(3)
Diabetic Ketoacidosis
669(14)
Dorothy J. Becker
Allan L. Drash
Oscar Escobar
Introduction
669(1)
Presentation and Clinical Features
669(1)
Pathogenesis
670(3)
Causes of Diabetic Ketoacidosis
673(1)
Differential Diagnosis
674(1)
Clinical Assessment
674(1)
Therapy
675(4)
Complications of DKA
679(1)
Preventive Therapy
680(3)
References
680(3)
VI. MISCELLANEOUS DISORDERS
Autoimmune Endocrinopathies
683(38)
William E. Winter
Autoimmunity and Autoimmune Diseases
683(6)
Classification and Recognition of Autoimmune Diseases
689(2)
Autoimmunity to the Pancreatic Islets, Insulin Receptors, and Insulin
691(6)
Autoimmune Thyroid Disease
697(5)
Autoimmune Addison's Disease
702(1)
Acquired Primary Gonadal Failure
703(1)
Idiopathic Hypoparathyroidism
703(1)
Hypophysitis and Autoimmune Disease of the Pituitary
704(1)
Autoimmune Diabetes Insipidus
704(1)
Associated Nonendocrine Autoimmune Diseases
704(1)
Autoimmune Disease Associations
705(2)
Clinical Approach to the Autoimmune Endocrinopathies and Related Diseases
707(1)
Summary
708(13)
References
708(13)
Multiple Endocrine Neoplasia Syndromes
721(14)
Giulia Costi
Noel K. Maclaren
Introduction
721(1)
MEN-1
721(2)
MEN-2
723(1)
Adrenal Adenoma
724(2)
Thyroid Adenomas
726(1)
Pituitary Adenomas
727(3)
Pancreatic Adenomas
730(5)
References
730(5)
Endocrine Tumors in Children
735(14)
Muhammad A. Jabbar
Introduction
735(1)
Adrenal Tumors
735(2)
Gonadal Tumors
737(3)
Tumors of Endocrine Pancreas
740(9)
References
745(4)
Nontraditional Inheritance of Endocrine Disorders
749(6)
Judith G. Hall
Introduction
749(1)
Uniparental Disomy
749(1)
Mosaicism
750(1)
Germline Mosaicism
751(1)
Genomic Imprinting
751(1)
Cytoplasmic Inheritance
752(1)
Summary
752(3)
References
752(3)
Disorders of Water Homeostasis
755(32)
Joseph A. Majzoub
Louis J. Muglia
Introduction
755(1)
Regulation of Thirst and Fluid Balance
755(6)
Central Diabetes Insipidus
761(6)
Nephrogenic Diabetes Insipidus
767(2)
Hyponatremia and the Syndrome of Inappropriate Secretion of Vasopressin
769(6)
Concluding Remarks
775(12)
References
776(11)
Emergencies of Inborn Metabolic Diseases
787(36)
Jose E. Abdenur
Introduction
787(1)
Urea Cycle Defects
787(5)
Organic Acidemias
792(6)
Fatty Acid Oxidation Defects
798(7)
Primary Lactic Acidemias
805(6)
Maple Syrup Urine Disease
811(12)
References
812(11)
Obesity in Children
823(36)
Ramin Alemzadeh
Russell Rising
Maribel Cedillo
Fima Lifshitz
Prevalence
823(1)
Morbidity
824(2)
Social Obesity
826(1)
Growth Assessment
827(4)
Who Is at Risk?
831(1)
Genetics
832(4)
Energy Balance
836(1)
Physical Activity
836(1)
Hyperinsulinism
837(1)
Hormonal Alterations
838(2)
Hypothalamus
840(1)
Treatment Modalities
840(1)
Diets
841(3)
Exercise
844(1)
Family Involvement
844(1)
Other Therapies
845(2)
Yo-Yo Weight Cycling
847(1)
Prevention
847(1)
Final Considerations
848(11)
References
848(11)
Hyperlipoproteinemias in Children and Adolescents
859(6)
Kurt Widhalm
Introduction
859(1)
Lipoprotein Background and Basics
859(1)
Definition of Hyperlipoproteinemia/Dyslipoproteinemia
860(1)
Familial Hypercholesterolemia
861(1)
Treatment
861(2)
Familial Combined Hyperlipidemia
863(1)
Hypertriglyceridemia/Chylomicronemia Syndrome
863(2)
References
863(2)
Endocrine Disorders After Cancer Therapy
865(10)
Raphael Rappaport
Elisabeth Thibaud
Introduction
865(1)
Growth
865(2)
Puberty
867(1)
Growth Hormone Secretion
867(1)
Thyroid
868(1)
Gonadal and Reproductive Function
868(2)
Other Endocrine Complications
870(1)
Follow-Up and Management
870(5)
References
871(4)
Endocrine Alterations in Human Immunodeficiency Virus Infections
875(20)
Robert Rapaport
Daphne Sack-Rivers
Introduction
875(1)
Growth
876(4)
Adrenal Function
880(2)
Thyroid
882(1)
Gonads
883(1)
Pancreas
884(1)
Parathyroid
885(1)
Prolactin
885(1)
Hypothalamus and Pituitary
885(1)
Endocrine Alterations Secondary to Treatment
886(1)
Future Hormonal Therapy in HIV Infections
886(1)
Conclusion
887(8)
References
887(8)
Hypertension in Children: Endocrine Considerations
895(22)
Julie R. Ingelfinger
Introduction
895(1)
Normal Blood Pressure and Its Definition
895(1)
Causes of Hypertension
895(1)
Complications of Hypertension: Patterns and Diagnosis
895(7)
Steroidogenic Enzyme Defects
902(1)
Primary Aldosteronism: Aldosterone-Producing Adenoma and Bilateral Adrenal Hyperplasia
903(2)
Glucocorticoid-Responsive Aldosteronism: Dexamethasone-Suppressible Hyperaldosteronism (OMIM 103900)
905(1)
Apparent Mineralocorticoid Excess (OMIM 218030)
906(1)
Mutations in Renal Transporters Causing Low-Renin Hypertension
906(1)
Cushing Syndrome and Hypertension
907(1)
Hypertension in Pheochromocytoma and Neural Crest Tumors
907(1)
Hypertension in Thyroid Disease
908(1)
Hyperparathyroidism and Hypertension
909(1)
Prevention of Hypertension and Endocrine Systems
909(1)
Primary Hypertension: How Often Endocrine?
909(1)
Treatment
909(8)
References
912(5)
VII. ADDITIONAL INFORMATION AND RESOURCES
Dietary Supplements to Enhance Athletic Performance
917(6)
Alan D. Rogol
Introduction
917(1)
Dietary Supplements: Herbal Products
917(1)
Ephedra
918(1)
Ginseng
918(1)
Creatine
918(1)
Anabolic Steroids
919(1)
Dehydroepiandrosterone
920(1)
Androstenedione
920(1)
Growth Hormone and Insulin-Like Growth Factor 1
921(1)
Conclusions
921(2)
References
921(2)
Using the Web to Obtain Information on Genetic and Hormone Disorders
923(12)
John A. Phillips III
Introduction
923(1)
Using the Web to Obtain Information for Dysmorphic Patients
924(1)
How to Generate a Differential Diagnosis for a Family Having Unusual Endocrine Problems
925(4)
How to Obtain Information on a Case of Endocrine Neoplasia
929(2)
Selected Web Sites on Growth and Hormone Disorders
931(2)
Conclusions
933(2)
References
933(2)
Hormone Measurements and Dynamic Tests in Pediatric Endocrinology
935(24)
Adriana A. Carrillo
Fred Chasalow
Introduction
935(1)
Role of the Laboratory
935(2)
Practical Considerations
937(1)
Practical Protocols for Dynamic Testing in Children
938(21)
References
955(4)
Reimbursement Issues in Endocrinology: A Coding Supplement
959(10)
Bridget F. Recker
Reimbursement
959(1)
CPT Coding
959(1)
ICD-9 (ICD-10 Coming)
960(1)
Linking CPT and ICD Coding
960(1)
Collections
961(1)
Denial and Appeal
961(1)
Contracting
962(1)
Chart Reviews
962(1)
Stimulation Testing
962(1)
Diabetic Education
963(1)
Clinical Trials
963(3)
What Is Needed?
966(1)
Frequently Used Diagnosed Codes for the Pediatric Endocrine Practice
967(2)
References
967(2)
Reference Charts Used Frequently by Endocrinologists in Assessing the Growth and Development of Youth
969(72)
Adriana A. Carillo
Bridget F. Recker
Standards of Growth and Development
971(27)
Miscellaneous Standards
998(13)
Standard Growth Charts for Children with Genetic or Pathological Conditions
1011(30)
Index 1041

Rewards Program

Write a Review